Structure Therapeutics Statistics
Total Valuation
GPCR has a market cap or net worth of $1.30 billion. The enterprise value is $450.90 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GPCR has 57.54 million shares outstanding. The number of shares has increased by 30.50% in one year.
Current Share Class | n/a |
Shares Outstanding | 57.54M |
Shares Change (YoY) | +30.50% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 5.80% |
Owned by Institutions (%) | 94.17% |
Float | 48.74M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.53 |
P/TBV Ratio | 1.55 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.29, with a Debt / Equity ratio of 0.01.
Current Ratio | 23.29 |
Quick Ratio | 22.94 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.85% and return on invested capital (ROIC) is -18.01%.
Return on Equity (ROE) | -22.85% |
Return on Assets (ROA) | -17.24% |
Return on Invested Capital (ROIC) | -18.01% |
Return on Capital Employed (ROCE) | -21.99% |
Revenue Per Employee | n/a |
Profits Per Employee | -$879,282 |
Employee Count | 163 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, GPCR has paid $379,000 in taxes.
Income Tax | 379,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.81% in the last 52 weeks. The beta is -1.97, so GPCR's price volatility has been lower than the market average.
Beta (5Y) | -1.97 |
52-Week Price Change | -57.81% |
50-Day Moving Average | 21.91 |
200-Day Moving Average | 29.83 |
Relative Strength Index (RSI) | 43.19 |
Average Volume (20 Days) | 725,532 |
Short Selling Information
Short Interest | 9.32M |
Short Previous Month | 9.14M |
Short % of Shares Out | 16.20% |
Short % of Float | 19.12% |
Short Ratio (days to cover) | 8.30 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -182.52M |
Pretax Income | -100.26M |
Net Income | -143.32M |
EBITDA | -181.48M |
EBIT | -182.52M |
Earnings Per Share (EPS) | -$2.59 |
Full Income Statement Balance Sheet
The company has $836.88 million in cash and $7.59 million in debt, giving a net cash position of $829.30 million or $14.41 per share.
Cash & Cash Equivalents | 836.88M |
Total Debt | 7.59M |
Net Cash | 829.30M |
Net Cash Per Share | $14.41 |
Equity (Book Value) | 824.64M |
Book Value Per Share | 14.33 |
Working Capital | 813.14M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$134.79 million and capital expenditures -$1.44 million, giving a free cash flow of -$136.23 million.
Operating Cash Flow | -134.79M |
Capital Expenditures | -1.44M |
Free Cash Flow | -136.23M |
FCF Per Share | -$2.37 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |